Response

Extract

Dr. Williams is correct that my reference to “the two SERMs now on the market” was inaccurate. It would have been not only more accurate, but also more in keeping with the aim of my article, to have written “the two SERMs now in the news.” My objective was to look beyond the publicity that had surrounded tamoxifen and raloxifene in the preceding few months and give an overview of SERMs currently in development.